# Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis

> **NCT05622526** · PHASE2 · UNKNOWN · sponsor: **Instituto de Investigación Marqués de Valdecilla** · enrollment: 96 (estimated)

## Conditions studied

- Patients With Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Group 1 or Experimental group
- **OTHER:** Group 2 or Control group

## Key facts

- **NCT ID:** NCT05622526
- **Lead sponsor:** Instituto de Investigación Marqués de Valdecilla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05622526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05622526, "Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05622526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*